Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
pentostatin
Medication labelWhy this: Advisory · dailymed-prescription
NIPENT is indicated as single-agent treatment for both untreated and alpha-interferon-refractory hairy cell leukemia patients with active disease as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms.
- generic_name
- pentostatin
- product_names
- PENTOSTATIN
- ndc
- 0409-0801, 0409-0801-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en